Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Romanos Sklavenitis Pistofidis, M.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma9202251971.100 Why?
HMGA1a Protein12021630.720 Why?
Waldenstrom Macroglobulinemia3202110760.510 Why?
Receptors, CXCR4120187280.440 Why?
RNA-Binding Proteins1202118740.390 Why?
Adaptor Proteins, Signal Transducing1202129000.350 Why?
Monoclonal Gammopathy of Undetermined Significance220201780.280 Why?
Gene Expression Regulation, Neoplastic1202186110.240 Why?
Neoplasm Recurrence, Local1202193730.200 Why?
Disease Models, Animal12021182930.190 Why?
Bone Marrow3202129210.190 Why?
Immunologic Factors2202215870.190 Why?
Clinical Trials, Phase II as Topic120226390.170 Why?
Disease Progression52022136320.160 Why?
Plasma Cells120215910.140 Why?
Receptor, Interferon alpha-beta120181130.140 Why?
Sequence Analysis, RNA2202120340.130 Why?
Mice, SCID1202126300.130 Why?
Stromal Cells1202113290.120 Why?
Mutation22019301980.120 Why?
Clone Cells1201816720.120 Why?
Cell Adhesion1202130890.110 Why?
Cell Proliferation22021104290.110 Why?
Tumor Cells, Cultured1202161130.110 Why?
Neoplasms, Experimental1201812290.100 Why?
Chromosome Aberrations1201817740.100 Why?
Tumor Microenvironment2202139460.090 Why?
Neoplasms, Second Primary1201810500.090 Why?
Antibodies, Viral1202132110.090 Why?
Base Sequence12021124030.080 Why?
Immunoglobulin G1202145280.080 Why?
Survival Rate22021127950.080 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815600.080 Why?
Cell Movement1202151940.080 Why?
Immune Tolerance1201823240.080 Why?
Decision Support Techniques1201920030.080 Why?
High-Throughput Nucleotide Sequencing1202036550.070 Why?
Asymptomatic Diseases220215860.070 Why?
Immunotherapy1202247520.070 Why?
Neoplasm Proteins1201835960.060 Why?
Prognosis32021299220.060 Why?
Apoptosis1202195140.060 Why?
T-Lymphocytes, Regulatory1201831110.060 Why?
Genomics1202059290.060 Why?
Humans1220227659680.050 Why?
Follow-Up Studies32019391930.050 Why?
Immunologic Tests120211010.050 Why?
Hematopoietic Stem Cell Transplantation1201857530.040 Why?
Risk2202295910.040 Why?
Models, Immunological120215170.040 Why?
Mice32021818190.040 Why?
beta 2-Microglobulin120193300.040 Why?
Antibodies, Blocking120182490.040 Why?
Antibodies, Neoplasm120182820.030 Why?
Female620213961120.030 Why?
Immunocompromised Host120218660.030 Why?
Myeloid Differentiation Factor 88120195820.030 Why?
Animals320211687640.030 Why?
Immunoglobulin M1201915280.030 Why?
Risk Factors42022748400.030 Why?
Male520213636980.020 Why?
Transplantation, Homologous1201848600.020 Why?
Disease-Free Survival1201968320.020 Why?
Biopsy1201967630.020 Why?
Combined Modality Therapy1201885290.020 Why?
Boston1201993380.020 Why?
Aged, 80 and over22020594890.010 Why?
Phenotype12022167210.010 Why?
Cell Line12018155430.010 Why?
Mice, Knockout12018144480.010 Why?
Predictive Value of Tests12019153980.010 Why?
Aged320201711170.010 Why?
Middle Aged320202230090.010 Why?
Adult320202230440.010 Why?
Risk Assessment12019242820.010 Why?
Time Factors12019400650.010 Why?
Prospective Studies12021548020.010 Why?
Signal Transduction12018236010.010 Why?
Sklavenitis Pistofidis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.